

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.57664835 |
| 2 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.45840131 |
| 3 | positive regulation of mast cell activation (GO:0033005) | 4.35745726 |
| 4 | regulation of gamma-delta T cell activation (GO:0046643) | 4.14345691 |
| 5 | B cell receptor signaling pathway (GO:0050853) | 3.96007214 |
| 6 | macrophage activation involved in immune response (GO:0002281) | 3.83536652 |
| 7 | positive regulation of mast cell degranulation (GO:0043306) | 3.73874929 |
| 8 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.73874929 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.67879786 |
| 10 | negative regulation of cell killing (GO:0031342) | 3.67879786 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 3.66586897 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 3.66586897 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 3.66586897 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.66586897 |
| 15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.66586897 |
| 16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.66586897 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 3.62205447 |
| 18 | cellular extravasation (GO:0045123) | 3.57846004 |
| 19 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.57235760 |
| 20 | nerve growth factor signaling pathway (GO:0038180) | 3.48686465 |
| 21 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.46229855 |
| 22 | cellular response to ethanol (GO:0071361) | 3.46142286 |
| 23 | microglial cell activation (GO:0001774) | 3.42153254 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.42048798 |
| 25 | regulation of mast cell activation (GO:0033003) | 3.41692500 |
| 26 | synaptic vesicle maturation (GO:0016188) | 3.27635529 |
| 27 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.23543439 |
| 28 | detection of other organism (GO:0098543) | 3.23000927 |
| 29 | response to peptidoglycan (GO:0032494) | 3.22377722 |
| 30 | negative regulation of interleukin-12 production (GO:0032695) | 3.18706973 |
| 31 | macrophage activation (GO:0042116) | 3.09947617 |
| 32 | myeloid cell activation involved in immune response (GO:0002275) | 3.01290230 |
| 33 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.00782841 |
| 34 | regulation of mast cell degranulation (GO:0043304) | 2.96206852 |
| 35 | positive regulation of B cell differentiation (GO:0045579) | 2.96053932 |
| 36 | detection of molecule of bacterial origin (GO:0032490) | 2.93608398 |
| 37 | positive regulation of granulocyte differentiation (GO:0030854) | 2.92117665 |
| 38 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.90432451 |
| 39 | detection of bacterium (GO:0016045) | 2.88519105 |
| 40 | immunoglobulin mediated immune response (GO:0016064) | 2.84580238 |
| 41 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.82882391 |
| 42 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.82204363 |
| 43 | negative regulation of T cell mediated immunity (GO:0002710) | 2.79856302 |
| 44 | histone H3-K4 trimethylation (GO:0080182) | 2.77917319 |
| 45 | response to host immune response (GO:0052572) | 2.77156392 |
| 46 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.77156392 |
| 47 | positive T cell selection (GO:0043368) | 2.74373078 |
| 48 | activated T cell proliferation (GO:0050798) | 2.74258647 |
| 49 | positive regulation of regulated secretory pathway (GO:1903307) | 2.73709907 |
| 50 | positive regulation of leukocyte degranulation (GO:0043302) | 2.73305651 |
| 51 | positive regulation of Rap GTPase activity (GO:0032854) | 2.72822753 |
| 52 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.72118244 |
| 53 | detection of external biotic stimulus (GO:0098581) | 2.71532534 |
| 54 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.71288190 |
| 55 | regulation of regulated secretory pathway (GO:1903305) | 2.70538707 |
| 56 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.70493330 |
| 57 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.67336471 |
| 58 | regulation of leukocyte degranulation (GO:0043300) | 2.65896495 |
| 59 | neutrophil activation (GO:0042119) | 2.65464212 |
| 60 | regulation of B cell differentiation (GO:0045577) | 2.64769744 |
| 61 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.63147814 |
| 62 | neutrophil mediated immunity (GO:0002446) | 2.60198554 |
| 63 | negative regulation of interleukin-17 production (GO:0032700) | 2.58433256 |
| 64 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.58371213 |
| 65 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.57580279 |
| 66 | positive thymic T cell selection (GO:0045059) | 2.56708018 |
| 67 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.56534795 |
| 68 | regulation of beta-amyloid formation (GO:1902003) | 2.55903096 |
| 69 | cell wall macromolecule catabolic process (GO:0016998) | 2.55756473 |
| 70 | positive regulation of developmental pigmentation (GO:0048087) | 2.54191376 |
| 71 | granulocyte activation (GO:0036230) | 2.53071248 |
| 72 | regulation of Rap GTPase activity (GO:0032317) | 2.51160328 |
| 73 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.45857550 |
| 74 | respiratory burst (GO:0045730) | 2.45754002 |
| 75 | myeloid leukocyte mediated immunity (GO:0002444) | 2.41805534 |
| 76 | regulation of tolerance induction (GO:0002643) | 2.41612153 |
| 77 | detection of biotic stimulus (GO:0009595) | 2.40464186 |
| 78 | negative thymic T cell selection (GO:0045060) | 2.39788036 |
| 79 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.39381483 |
| 80 | germinal center formation (GO:0002467) | 2.39260035 |
| 81 | regulation of granulocyte differentiation (GO:0030852) | 2.38434528 |
| 82 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.36462577 |
| 83 | locomotory exploration behavior (GO:0035641) | 2.36381639 |
| 84 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.36108804 |
| 85 | negative T cell selection (GO:0043383) | 2.33338361 |
| 86 | T cell selection (GO:0045058) | 2.33041135 |
| 87 | establishment of protein localization to Golgi (GO:0072600) | 2.31960647 |
| 88 | positive regulation of antigen processing and presentation (GO:0002579) | 2.31778784 |
| 89 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.31017539 |
| 90 | T cell proliferation (GO:0042098) | 2.31008091 |
| 91 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.29934247 |
| 92 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.28607728 |
| 93 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.28218449 |
| 94 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.27901818 |
| 95 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.26870454 |
| 96 | response to nerve growth factor (GO:1990089) | 2.26870454 |
| 97 | defense response to protozoan (GO:0042832) | 2.26559236 |
| 98 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.26002104 |
| 99 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.25566820 |
| 100 | response to host defenses (GO:0052200) | 2.25566820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.78944509 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.21292890 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.86252182 |
| 4 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.74469445 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.60728266 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.59734472 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.53827115 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.14750617 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 2.13502659 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.13462679 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.07209286 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.06851453 |
| 13 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.97899702 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.94669515 |
| 15 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.94071035 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.82905501 |
| 17 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.82080312 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.79316370 |
| 19 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.73782401 |
| 20 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.73657198 |
| 21 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.73115212 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.71415268 |
| 23 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.70512934 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.65790417 |
| 25 | SPI1_23127762_ChIP-Seq_K562_Human | 1.63507541 |
| 26 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.62969198 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.56686793 |
| 28 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.55974019 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.55593427 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.52737946 |
| 31 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.52035013 |
| 32 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.51275695 |
| 33 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.44301292 |
| 34 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43743770 |
| 35 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.42991463 |
| 36 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.42252807 |
| 37 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.42252807 |
| 38 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41987700 |
| 39 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35449332 |
| 40 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.33668034 |
| 41 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.32987366 |
| 42 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32589047 |
| 43 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.32306173 |
| 44 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.31057376 |
| 45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29599922 |
| 46 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28194136 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.28001247 |
| 48 | TCF4_23295773_ChIP-Seq_U87_Human | 1.27392920 |
| 49 | MYB_26560356_Chip-Seq_TH2_Human | 1.24228992 |
| 50 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.21141335 |
| 51 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19035043 |
| 52 | P300_19829295_ChIP-Seq_ESCs_Human | 1.15584406 |
| 53 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.14588833 |
| 54 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.12780874 |
| 55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11420308 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11250768 |
| 57 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10321782 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08684160 |
| 59 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.08678647 |
| 60 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.08539142 |
| 61 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.07821957 |
| 62 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.07722880 |
| 63 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.07503991 |
| 64 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.07213292 |
| 65 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06003437 |
| 66 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.04659486 |
| 67 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.02923045 |
| 68 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01502636 |
| 69 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99878684 |
| 70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.99773776 |
| 71 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.99705489 |
| 72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99519364 |
| 73 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.99139532 |
| 74 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.98961515 |
| 75 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.98785181 |
| 76 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.98442459 |
| 77 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98239537 |
| 78 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98117635 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98091062 |
| 80 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97093628 |
| 81 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96726306 |
| 82 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96678030 |
| 83 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95714016 |
| 84 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.94056540 |
| 85 | KDM2B_26808549_Chip-Seq_REH_Human | 0.93744690 |
| 86 | AR_25329375_ChIP-Seq_VCAP_Human | 0.93553423 |
| 87 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.93476042 |
| 88 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93083941 |
| 89 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.92179376 |
| 90 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.91695009 |
| 91 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.91027597 |
| 92 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.91012613 |
| 93 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.90850456 |
| 94 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.90842801 |
| 95 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.90413612 |
| 96 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.90273613 |
| 97 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.90273613 |
| 98 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.89641989 |
| 99 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.89591459 |
| 100 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.89264185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 3.43534408 |
| 2 | MP0003172_abnormal_lysosome_physiology | 2.93953970 |
| 3 | MP0003787_abnormal_imprinting | 2.90554925 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.88401974 |
| 5 | MP0003303_peritoneal_inflammation | 2.79163978 |
| 6 | MP0003724_increased_susceptibility_to | 2.71552087 |
| 7 | MP0005671_abnormal_response_to | 2.34749244 |
| 8 | MP0003300_gastrointestinal_ulcer | 2.25435181 |
| 9 | MP0003690_abnormal_glial_cell | 2.09685981 |
| 10 | MP0005379_endocrine/exocrine_gland_phen | 2.00967214 |
| 11 | MP0001800_abnormal_humoral_immune | 1.97341968 |
| 12 | MP0001790_abnormal_immune_system | 1.86447560 |
| 13 | MP0005387_immune_system_phenotype | 1.86447560 |
| 14 | MP0002419_abnormal_innate_immunity | 1.86150895 |
| 15 | MP0005464_abnormal_platelet_physiology | 1.86062646 |
| 16 | MP0002009_preneoplasia | 1.82244954 |
| 17 | MP0005000_abnormal_immune_tolerance | 1.80599233 |
| 18 | MP0000685_abnormal_immune_system | 1.72101331 |
| 19 | MP0002452_abnormal_antigen_presenting | 1.72096132 |
| 20 | MP0004381_abnormal_hair_follicle | 1.70914643 |
| 21 | MP0004270_analgesia | 1.69471940 |
| 22 | MP0005075_abnormal_melanosome_morpholog | 1.68681102 |
| 23 | MP0002723_abnormal_immune_serum | 1.64936516 |
| 24 | MP0000015_abnormal_ear_pigmentation | 1.64074313 |
| 25 | MP0008057_abnormal_DNA_replication | 1.63603920 |
| 26 | MP0002420_abnormal_adaptive_immunity | 1.62374605 |
| 27 | MP0005025_abnormal_response_to | 1.60889502 |
| 28 | MP0001819_abnormal_immune_cell | 1.59799669 |
| 29 | MP0005310_abnormal_salivary_gland | 1.59115235 |
| 30 | MP0004859_abnormal_synaptic_plasticity | 1.54153405 |
| 31 | MP0005058_abnormal_lysosome_morphology | 1.53096512 |
| 32 | MP0002638_abnormal_pupillary_reflex | 1.50306229 |
| 33 | MP0006082_CNS_inflammation | 1.48441801 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.48335597 |
| 35 | MP0003436_decreased_susceptibility_to | 1.45551705 |
| 36 | MP0009046_muscle_twitch | 1.45031932 |
| 37 | MP0002909_abnormal_adrenal_gland | 1.44484296 |
| 38 | MP0002822_catalepsy | 1.42986448 |
| 39 | MP0008877_abnormal_DNA_methylation | 1.42437589 |
| 40 | MP0005174_abnormal_tail_pigmentation | 1.41077945 |
| 41 | MP0000604_amyloidosis | 1.39217507 |
| 42 | MP0004130_abnormal_muscle_cell | 1.38756621 |
| 43 | MP0002064_seizures | 1.36378954 |
| 44 | MP0001501_abnormal_sleep_pattern | 1.35747547 |
| 45 | MP0003635_abnormal_synaptic_transmissio | 1.33630040 |
| 46 | MP0009745_abnormal_behavioral_response | 1.33359737 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.27428794 |
| 48 | MP0002405_respiratory_system_inflammati | 1.26614127 |
| 49 | MP0002398_abnormal_bone_marrow | 1.26050481 |
| 50 | MP0000716_abnormal_immune_system | 1.25361529 |
| 51 | MP0009785_altered_susceptibility_to | 1.25324961 |
| 52 | MP0010386_abnormal_urinary_bladder | 1.25093119 |
| 53 | MP0002396_abnormal_hematopoietic_system | 1.22220447 |
| 54 | MP0003633_abnormal_nervous_system | 1.21860017 |
| 55 | MP0002163_abnormal_gland_morphology | 1.19499911 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.17918414 |
| 57 | MP0001545_abnormal_hematopoietic_system | 1.17918414 |
| 58 | MP0002693_abnormal_pancreas_physiology | 1.17311144 |
| 59 | MP0002063_abnormal_learning/memory/cond | 1.16751373 |
| 60 | MP0009278_abnormal_bone_marrow | 1.16614303 |
| 61 | MP0003632_abnormal_nervous_system | 1.15353175 |
| 62 | MP0002166_altered_tumor_susceptibility | 1.15245943 |
| 63 | MP0002733_abnormal_thermal_nociception | 1.14213996 |
| 64 | MP0000689_abnormal_spleen_morphology | 1.12923125 |
| 65 | MP0003631_nervous_system_phenotype | 1.09315751 |
| 66 | MP0003763_abnormal_thymus_physiology | 1.07175657 |
| 67 | MP0001970_abnormal_pain_threshold | 1.07106195 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 1.04901467 |
| 69 | MP0005646_abnormal_pituitary_gland | 1.03974244 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 1.02928007 |
| 71 | MP0001845_abnormal_inflammatory_respons | 1.02176983 |
| 72 | MP0005535_abnormal_body_temperature | 0.93069986 |
| 73 | MP0000371_diluted_coat_color | 0.92704809 |
| 74 | MP0002722_abnormal_immune_system | 0.92206206 |
| 75 | MP0002272_abnormal_nervous_system | 0.91049183 |
| 76 | MP0002734_abnormal_mechanical_nocicepti | 0.89702575 |
| 77 | MP0002572_abnormal_emotion/affect_behav | 0.89054958 |
| 78 | MP0002429_abnormal_blood_cell | 0.88673636 |
| 79 | MP0001486_abnormal_startle_reflex | 0.86310719 |
| 80 | MP0009115_abnormal_fat_cell | 0.85938157 |
| 81 | MP0004808_abnormal_hematopoietic_stem | 0.85578660 |
| 82 | MP0003329_amyloid_beta_deposits | 0.83235740 |
| 83 | MP0003045_fibrosis | 0.82356566 |
| 84 | MP0003866_abnormal_defecation | 0.81856725 |
| 85 | MP0002928_abnormal_bile_duct | 0.80338477 |
| 86 | MP0000920_abnormal_myelination | 0.80324034 |
| 87 | MP0002067_abnormal_sensory_capabilities | 0.79278576 |
| 88 | MP0003195_calcinosis | 0.79102360 |
| 89 | MP0003828_pulmonary_edema | 0.78903880 |
| 90 | MP0001440_abnormal_grooming_behavior | 0.78550760 |
| 91 | MP0003075_altered_response_to | 0.77218590 |
| 92 | MP0003879_abnormal_hair_cell | 0.77166018 |
| 93 | MP0001968_abnormal_touch/_nociception | 0.77044199 |
| 94 | MP0000703_abnormal_thymus_morphology | 0.77036686 |
| 95 | MP0008569_lethality_at_weaning | 0.76493879 |
| 96 | MP0005647_abnormal_sex_gland | 0.76058137 |
| 97 | MP0005220_abnormal_exocrine_pancreas | 0.75217646 |
| 98 | MP0002998_abnormal_bone_remodeling | 0.74609794 |
| 99 | MP0002229_neurodegeneration | 0.74601361 |
| 100 | MP0003121_genomic_imprinting | 0.72726036 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 4.23401365 |
| 2 | Recurrent abscess formation (HP:0002722) | 3.77707100 |
| 3 | Abnormality of macrophages (HP:0004311) | 3.52547581 |
| 4 | Eczematoid dermatitis (HP:0000976) | 3.51003408 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.00557650 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.88280082 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.88280082 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 2.88280082 |
| 9 | Recurrent fungal infections (HP:0002841) | 2.85658207 |
| 10 | Increased cerebral lipofuscin (HP:0011813) | 2.78443609 |
| 11 | Stomatitis (HP:0010280) | 2.76771771 |
| 12 | Prolonged bleeding time (HP:0003010) | 2.76500600 |
| 13 | Optic neuritis (HP:0100653) | 2.75779897 |
| 14 | Retrobulbar optic neuritis (HP:0100654) | 2.75779897 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 2.69098888 |
| 16 | Recurrent cutaneous fungal infections (HP:0011370) | 2.68903177 |
| 17 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.68903177 |
| 18 | Recurrent skin infections (HP:0001581) | 2.68868851 |
| 19 | Mutism (HP:0002300) | 2.61906853 |
| 20 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.56501976 |
| 21 | Spontaneous hematomas (HP:0007420) | 2.52228908 |
| 22 | Febrile seizures (HP:0002373) | 2.48926156 |
| 23 | Disinhibition (HP:0000734) | 2.48661712 |
| 24 | Meningitis (HP:0001287) | 2.48038292 |
| 25 | Agitation (HP:0000713) | 2.47676435 |
| 26 | Neonatal hypoglycemia (HP:0001998) | 2.46598689 |
| 27 | Albinism (HP:0001022) | 2.44874840 |
| 28 | Progressive cerebellar ataxia (HP:0002073) | 2.42128838 |
| 29 | Vasculitis (HP:0002633) | 2.40860486 |
| 30 | Colitis (HP:0002583) | 2.37626604 |
| 31 | Papilledema (HP:0001085) | 2.36615599 |
| 32 | Orchitis (HP:0100796) | 2.35573648 |
| 33 | Myositis (HP:0100614) | 2.35468002 |
| 34 | Gingival bleeding (HP:0000225) | 2.35073576 |
| 35 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.33355598 |
| 36 | Obstructive lung disease (HP:0006536) | 2.30667535 |
| 37 | Chronic obstructive pulmonary disease (HP:0006510) | 2.30667535 |
| 38 | T lymphocytopenia (HP:0005403) | 2.28675993 |
| 39 | Vacuolated lymphocytes (HP:0001922) | 2.26989350 |
| 40 | Inappropriate behavior (HP:0000719) | 2.26536012 |
| 41 | Hyperventilation (HP:0002883) | 2.25104064 |
| 42 | Protruding tongue (HP:0010808) | 2.23341154 |
| 43 | Focal motor seizures (HP:0011153) | 2.22358573 |
| 44 | Acute lymphatic leukemia (HP:0006721) | 2.22084403 |
| 45 | Gastrointestinal infarctions (HP:0005244) | 2.20970668 |
| 46 | Hemoptysis (HP:0002105) | 2.16213931 |
| 47 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.13632197 |
| 48 | Recurrent viral infections (HP:0004429) | 2.12388974 |
| 49 | Excessive salivation (HP:0003781) | 2.06626649 |
| 50 | Widely spaced teeth (HP:0000687) | 2.06501242 |
| 51 | Abnormality of T cell number (HP:0011839) | 2.06166450 |
| 52 | Epistaxis (HP:0000421) | 2.04347694 |
| 53 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.04009220 |
| 54 | Gingivitis (HP:0000230) | 2.03671035 |
| 55 | Gaze-evoked nystagmus (HP:0000640) | 2.02582997 |
| 56 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.01327959 |
| 57 | Drooling (HP:0002307) | 2.01321422 |
| 58 | Chest pain (HP:0100749) | 2.00840596 |
| 59 | Encephalitis (HP:0002383) | 2.00650300 |
| 60 | Hematochezia (HP:0002573) | 1.99160737 |
| 61 | Inflammation of the large intestine (HP:0002037) | 1.98900699 |
| 62 | Polyphagia (HP:0002591) | 1.96507679 |
| 63 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.96471554 |
| 64 | Dysostosis multiplex (HP:0000943) | 1.93957098 |
| 65 | Episodic fever (HP:0001954) | 1.93208630 |
| 66 | Recurrent sinusitis (HP:0011108) | 1.91748873 |
| 67 | Focal seizures (HP:0007359) | 1.91149724 |
| 68 | Pulmonary embolism (HP:0002204) | 1.90199472 |
| 69 | Papillary thyroid carcinoma (HP:0002895) | 1.89939670 |
| 70 | Postural instability (HP:0002172) | 1.85702715 |
| 71 | Hypoplasia of the fovea (HP:0007750) | 1.85293034 |
| 72 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.85293034 |
| 73 | Keratoconjunctivitis sicca (HP:0001097) | 1.85193458 |
| 74 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.84803586 |
| 75 | Gastrointestinal inflammation (HP:0004386) | 1.84061050 |
| 76 | Absent speech (HP:0001344) | 1.83272356 |
| 77 | Pheochromocytoma (HP:0002666) | 1.81078332 |
| 78 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.79307678 |
| 79 | Truncal obesity (HP:0001956) | 1.78742163 |
| 80 | Pulmonary infiltrates (HP:0002113) | 1.78618729 |
| 81 | Arterial thrombosis (HP:0004420) | 1.78187658 |
| 82 | Genetic anticipation (HP:0003743) | 1.77589365 |
| 83 | Memory impairment (HP:0002354) | 1.77476509 |
| 84 | Abnormality of the prostate (HP:0008775) | 1.75917149 |
| 85 | Panhypogammaglobulinemia (HP:0003139) | 1.75014709 |
| 86 | Abnormality of the periventricular white matter (HP:0002518) | 1.74510714 |
| 87 | Keratoconjunctivitis (HP:0001096) | 1.74023477 |
| 88 | Congenital stationary night blindness (HP:0007642) | 1.73940219 |
| 89 | Amaurosis fugax (HP:0100576) | 1.73871577 |
| 90 | Increased CSF protein (HP:0002922) | 1.73458528 |
| 91 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.72262337 |
| 92 | Hemiplegia (HP:0002301) | 1.71597608 |
| 93 | Abnormality of binocular vision (HP:0011514) | 1.71539805 |
| 94 | Diplopia (HP:0000651) | 1.71539805 |
| 95 | Global brain atrophy (HP:0002283) | 1.71063097 |
| 96 | Gastrointestinal stroma tumor (HP:0100723) | 1.70755510 |
| 97 | Abnormality of the fingertips (HP:0001211) | 1.70252794 |
| 98 | Severe visual impairment (HP:0001141) | 1.69402440 |
| 99 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.69046159 |
| 100 | Generalized hypopigmentation (HP:0007513) | 1.68384909 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.73686043 |
| 2 | BLK | 3.02192234 |
| 3 | FRK | 2.98703182 |
| 4 | DAPK2 | 2.10225409 |
| 5 | FES | 2.09225204 |
| 6 | MAP4K1 | 1.88682867 |
| 7 | SYK | 1.80879244 |
| 8 | FGR | 1.78726409 |
| 9 | NTRK3 | 1.76486754 |
| 10 | ACVR1B | 1.71408751 |
| 11 | CSK | 1.69448576 |
| 12 | SGK2 | 1.68032941 |
| 13 | BRD4 | 1.61646421 |
| 14 | CAMK1G | 1.61582608 |
| 15 | MAP3K13 | 1.55331738 |
| 16 | CASK | 1.48612120 |
| 17 | MAP3K14 | 1.48442034 |
| 18 | TYK2 | 1.47070142 |
| 19 | CAMK1D | 1.44001725 |
| 20 | BTK | 1.41349375 |
| 21 | MATK | 1.40102271 |
| 22 | SIK2 | 1.30647498 |
| 23 | IRAK4 | 1.29502549 |
| 24 | CSF1R | 1.24854042 |
| 25 | MAP3K9 | 1.24128986 |
| 26 | MARK2 | 1.23606046 |
| 27 | TEC | 1.20620714 |
| 28 | SGK3 | 1.20233240 |
| 29 | CAMKK2 | 1.18468434 |
| 30 | MAP3K4 | 1.18083587 |
| 31 | LYN | 1.15687786 |
| 32 | CDK19 | 1.13907330 |
| 33 | TAOK3 | 1.13573813 |
| 34 | SGK494 | 1.12656697 |
| 35 | SGK223 | 1.12656697 |
| 36 | ITK | 1.10409892 |
| 37 | TNK2 | 1.09566535 |
| 38 | BMPR2 | 1.08064017 |
| 39 | PDK1 | 1.07014033 |
| 40 | JAK2 | 1.06849348 |
| 41 | TXK | 1.06838692 |
| 42 | YES1 | 1.05677375 |
| 43 | CAMKK1 | 1.03035145 |
| 44 | PRPF4B | 1.02768785 |
| 45 | FGFR3 | 1.02261778 |
| 46 | HCK | 1.02185089 |
| 47 | NTRK2 | 0.98525348 |
| 48 | JAK1 | 0.95603058 |
| 49 | ZAP70 | 0.95128828 |
| 50 | STK11 | 0.94475698 |
| 51 | KIT | 0.91974664 |
| 52 | NLK | 0.91186750 |
| 53 | MAPK13 | 0.91168650 |
| 54 | MAP2K4 | 0.90694981 |
| 55 | JAK3 | 0.89021126 |
| 56 | LCK | 0.85586938 |
| 57 | RET | 0.84167446 |
| 58 | MAP3K2 | 0.83231406 |
| 59 | WNK1 | 0.82864252 |
| 60 | IKBKE | 0.80428506 |
| 61 | TYRO3 | 0.79068388 |
| 62 | BMPR1B | 0.79021320 |
| 63 | ADRBK2 | 0.78840007 |
| 64 | PDPK1 | 0.78143001 |
| 65 | CAMK1 | 0.76016546 |
| 66 | PRKCQ | 0.74478152 |
| 67 | AKT3 | 0.74300295 |
| 68 | SGK1 | 0.72528195 |
| 69 | MAP3K7 | 0.71127633 |
| 70 | MAPK12 | 0.67793475 |
| 71 | KSR2 | 0.66200743 |
| 72 | STK24 | 0.66108282 |
| 73 | MARK1 | 0.65837718 |
| 74 | FGFR2 | 0.63682471 |
| 75 | PRKCH | 0.63673131 |
| 76 | MARK3 | 0.62453089 |
| 77 | CDK12 | 0.61954411 |
| 78 | TAOK1 | 0.59091523 |
| 79 | CDK5 | 0.57738141 |
| 80 | PRKAA2 | 0.56907435 |
| 81 | CAMK4 | 0.56656783 |
| 82 | IKBKB | 0.56501803 |
| 83 | MAP3K1 | 0.56289274 |
| 84 | TNIK | 0.54995560 |
| 85 | CDC42BPA | 0.52989167 |
| 86 | CDK6 | 0.52324533 |
| 87 | DYRK1A | 0.52162474 |
| 88 | HIPK2 | 0.50870371 |
| 89 | MAP2K3 | 0.49843735 |
| 90 | FYN | 0.48381181 |
| 91 | PRKCZ | 0.48008226 |
| 92 | STK3 | 0.46737057 |
| 93 | GRK7 | 0.46016139 |
| 94 | ALK | 0.44677746 |
| 95 | MAPK7 | 0.43514245 |
| 96 | EGFR | 0.43349331 |
| 97 | PAK3 | 0.42848519 |
| 98 | IRAK1 | 0.38454935 |
| 99 | MAP2K6 | 0.37563707 |
| 100 | OXSR1 | 0.37467417 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.42403297 |
| 2 | Asthma_Homo sapiens_hsa05310 | 2.30938746 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.29664820 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.14170363 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.13349488 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.10531818 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.07250750 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.05752335 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.88058741 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.87617876 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 1.77325190 |
| 12 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.59366725 |
| 13 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.56344802 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.50744170 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 1.45570936 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.43615776 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.42986538 |
| 18 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.39432455 |
| 19 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.39365198 |
| 20 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.37575356 |
| 21 | Long-term potentiation_Homo sapiens_hsa04720 | 1.36644974 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.36388063 |
| 23 | Nicotine addiction_Homo sapiens_hsa05033 | 1.35064229 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.34873855 |
| 25 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.30994765 |
| 26 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.26050348 |
| 27 | Platelet activation_Homo sapiens_hsa04611 | 1.23265146 |
| 28 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.21389989 |
| 29 | GABAergic synapse_Homo sapiens_hsa04727 | 1.21015531 |
| 30 | Lysosome_Homo sapiens_hsa04142 | 1.17765354 |
| 31 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.16822561 |
| 32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.15719006 |
| 33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.13709730 |
| 34 | Circadian entrainment_Homo sapiens_hsa04713 | 1.10015327 |
| 35 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.09830732 |
| 36 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.08443667 |
| 37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.04873326 |
| 38 | Long-term depression_Homo sapiens_hsa04730 | 1.03628509 |
| 39 | Insulin secretion_Homo sapiens_hsa04911 | 1.01669608 |
| 40 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.01423393 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.01330652 |
| 42 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.98955161 |
| 43 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.97615294 |
| 44 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95642713 |
| 45 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.95622555 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.95499987 |
| 47 | Renin secretion_Homo sapiens_hsa04924 | 0.94775795 |
| 48 | Other glycan degradation_Homo sapiens_hsa00511 | 0.94740277 |
| 49 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94021090 |
| 50 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.91797061 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.91390501 |
| 52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.91329347 |
| 53 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.90970249 |
| 54 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.88098909 |
| 55 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.86881504 |
| 56 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.86827838 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 0.85698338 |
| 58 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.85562421 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85248914 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84918746 |
| 61 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.84499905 |
| 62 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.82863909 |
| 63 | Measles_Homo sapiens_hsa05162 | 0.81332889 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81106220 |
| 65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80720024 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79890036 |
| 67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.79396166 |
| 68 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.77432379 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76331900 |
| 70 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.75321155 |
| 71 | Viral myocarditis_Homo sapiens_hsa05416 | 0.73629974 |
| 72 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71809779 |
| 73 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.68779562 |
| 74 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68165870 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.67657755 |
| 76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67526224 |
| 77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67201969 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66936922 |
| 79 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.65983309 |
| 80 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.63231672 |
| 81 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.62398869 |
| 82 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.62216251 |
| 83 | Salivary secretion_Homo sapiens_hsa04970 | 0.62176397 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61054610 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.60656111 |
| 86 | Glioma_Homo sapiens_hsa05214 | 0.60626440 |
| 87 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.60332633 |
| 88 | Legionellosis_Homo sapiens_hsa05134 | 0.60281859 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59235445 |
| 90 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.58821855 |
| 91 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58605030 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55951858 |
| 93 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.55537945 |
| 94 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54820835 |
| 95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54401371 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54382915 |
| 97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53791235 |
| 98 | Phototransduction_Homo sapiens_hsa04744 | 0.53250996 |
| 99 | Hepatitis B_Homo sapiens_hsa05161 | 0.50383824 |
| 100 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.49618608 |

